|
|
Article: Kunming Pharmaceutical launches artemisinin project.(NEWSDESK: Expansion)
- Article from:
- China Chemical Reporter
- Article date:
- March 26, 2007
CopyrightCOPYRIGHT 2007 China National Chemical Information Center. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Kunming Pharmaceutical Corp. (SH: 600422) announced on February 27th that the Board of Directors of the company had decided to launch an artemisinin compound antiperiodic ARCO project.
The 4 100 [m.sup.2] project mainly produces ARCO and the design capacity is I00 million pcs/a tablets and 50 million pcs/ a capsules. The construction period is one year. The total investment is RMB49.89 million including RMB39.89 million to be raised by the company itself and RMB10.0 million to be supported by ...